Impact of bedaquiline on treatment outcomes of multidrug-resistant tuberculosis in a high-burden country.

Dumitru ChesovJan HeyckendorfSofia AlexandruAna DonicaElena ChesovMaja ReimannValeriu CruduVictor BotnaruChristoph Lange

Published in: The European respiratory journal (2021)

Bedaquiline-based MDR-TB treatment regimens result in better disease resolution when compared with bedaquiline-sparing MDR-TB treatment regimens under programmatic conditions in a country with a high burden of MDR-TB.

Keyphrases

multidrug resistant
drug resistant
gram negative
acinetobacter baumannii
mycobacterium tuberculosis
klebsiella pneumoniae
risk factors
emergency department
escherichia coli
cystic fibrosis
pulmonary tuberculosis
hiv aids
hiv infected
adverse drug
drug induced